Gender and Age Variation on the Prevalence of Staphylococcus Species from Clinical Isolates in Esan Land, Nigeria
[1]
Momoh Abdul-Razaq McSionel, Department of Medical Microbiology, Ambrose Alli University, Ekpoma, Nigeria.
[2]
Morgan Eghosa, Department of Surgery, Irrua Specialist Teaching Hospital, Irrua, Nigeria.
[3]
Okolo Patrick Osarenoma, Department of Medical Microbiology, Ambrose Alli University, Ekpoma, Nigeria.
[4]
Adewuyi Gbolagade Morufu, Department of Medical Microbiology, Irrua Specialist Teaching Hospital, Irrua, Nigeria.
[5]
Iyang Johnson, Department of Medical Microbiology, Irrua Specialist Teaching Hospital, Irrua, Nigeria.
[6]
Orhue Ogbeide Philips, Department of Medical Laboratory Sciences, Ambrose Alli University, Ekpoma, Nigeria.
This study examines the effect of gender and age differences on the distribution of Staphylococcus species (S . spp) among in and out patients of 3 health facilities in Esan, Nigeria. In a bid to achieve this objective, 863mid-stream urine of patients attending the Irrua Specialist Teaching Hospital, Irrua, Gilead Hospital Center, Ekpoma and Calvary Medical Centre, Ekpoma, were assessed for staphylococcus infection. The samples were retrospective specimens from male and female (15 to 60+years) during January and December, 2013. The results showed 406 samples (47.05%) were positive for Staphylococcus species isolates made up of 59.11% males and 40.89% females. S. aureus counted for 81.53% while S. saprophyticus and S. epidermidis accounted for 16.50% and 1.97% respectively. All the age groups were positive for S. aureus while ages ranging from 25 to 44 years were only positive for S. epidermidis in both gender. However, male within ages 55 and above and female between ages 50 and 54 were negative for S. saprophyticus. This study showed that there are age and gender variations in the distribution of Staphylococcus spp and that these factors could be considerable risk factors Staphylococcus infection treatments.
[1]
Galatti L., Sessa A., Mazzaglia G., et al., Antibiotic prescribing for acute and recurrent cystitis in primary care: a 4 year descriptive study. Journal of Antimicrobial Chemotherapy 2006, vol. 57, no. 3, pp. 551–556.
[2]
Ronald A. R., Nicolle L. E., Stamm E., et al. Urinary tract infection in adults: research priorities and strategies. Int J Antimicrob Agents2001; 17: 343-8.
[3]
Foxman B., Barlow R., D'Arcy H., Gillespie B., Sobel J. D. Urinary tract infection: self-reported incidence and associated costs. Annals of Epidemiology 2000; 10 (8): 509–515.
[4]
Litwin M. S., Saigal C. S., Yano E. M., et al., Urologic diseases in America project: analytical methods and principal findings. Journal of Urology 2005; 173 (3): 933–937.
[5]
Royal College of General Practitioners, Office of Population Censuses and Surveys, Department of Health, Morbidity Statistics from General Practice: Fourth National Study 1991-1992, Series MB5, no. 3, HMSO, London, UK, 1995.
[6]
Kahlmeter G. An international survey of the antimicrobial susceptibility of pathogens from uncomplicated urinary tract infections: the ECO. SENS project. Journal of Antimicrobial Chemotherapy 2003; 51 (1): 69–76.
[7]
Farrell D. J., Morrissey I., Robeis D., Robbins M., Felmingham D. AUK multicentre study of the antimicrobial susceptibility of bacterial pathogens causing urinary tract infections. J. infect. 2003; 46: 94-100.
[8]
Megged O. Staphylococcus aureus urinary tract infections in children are associated with urinary tract abnormalities and vesico-ureteral reflux. Pediatr. Nephrol. 2014; 29: 269-272.
[9]
Kaper J. B., Nataro J. P., Mobley H. L. T. Pathogenic Escherichia coli. Nat. Rev. Microbiol. 2004; 2: 123-140.
[10]
Upadhyayula S., Kambalapalli M., Asmar B. I. Staphylococcus epidermidis urinary tract infection in an infant. Case Rep. Infect. Dis. 2012; 10.1155/2012/983153.
[11]
Sousa V. S. D., RabelloR. F., da Silva DiasR. C., Martins I. S., da Silva dos SantosL. B. G., et al., Time-based distribution of Staphylococcus saprophyticus pulsed field gel-electrophoresis clusters in community-acquired urinary tract infections. Memorias Instituto Oswaldo Cruz 2013; 108: 73-76.
[12]
Onanuga A., Awhowho G. O. Antimicrobial resistance of Staphylococcus aureus strains from patients with urinary tract infections in Yenagoa, Nigeria. J Pharm Bioallied Sci. 2012; 4 (3): 226–230.
[13]
Totsika M., MorielD. G., IdrisA., RogersB. A., Wurpel D. J., et al., Uropathogenic Escherichia coli mediated urinary tract infection. Curr. Drug Targets 2012; 13: 1386-1399.
[14]
Ferreira A. M., Bonesso M. F., Mondelli A. L., Camargo C. H., Cunha M. L. R. S. Oxacillin Resistance and Antimicrobial Susceptibility Profile of Staphylococcus saprophyticus and Other Staphylococci Isolated from Patients with Urinary Tract Infection. Chemotherapy 2012; 58: 482-491.
[15]
Lunacek A., KoenigU., MrstikC., RadmayrC., Horninger W., Plas E. Unexpected multidrug resistance of methicillin-resistant Staphylococcus aureus in urine samples: A single-center study. Korean J. Urol. 2014; 55: 349-353.
[16]
Orret F. A., Davis G. K. A comparison of the antimicrobial susceptibility profile of urinary pathogens for the years 1999 and 2003. West Indian Med. J. 2006; 55, 95-99.
[17]
Omoregie R., Erebor J. O., Ahonkhai I., Isibor J. O., Ogefere H. O. Observed changes in the prevalence of uropathogens in Benin City, Nigeria. New Zeal. Journ. Med. Lab. Sci. 2008; 62, 29-33.
[18]
Brady K. A., Berry S., Gupta R., Weiner M, Turner B. J. Seasonal variaton in undiagnosed HIV infection on the general medicine and trauma services in two urban hospitals. J Gen. Intern. Med. 2005; 20: 324–30.
[19]
Castagno L. A, Levinsky L. Otitis media in children: seasonal changes and socioeconomic level. Int. J. Pediatr. Otorhinolaryngol. 2002; 62 (2): 129–34.
[20]
Momoh A. RM., Orhue O. P., Akpamu U., Okolo P. O. Prevalence of Staphylococci Strains Among Apparently Healthy Co-habiting Opposite Sex Partners with Cases of Urinary Tract Infections. International Journal of Microbiology and Application, 2017; 4 (3) 19-24.
[21]
Ebie M., Kandki-Olukemi Y. T., Ayanbadejo J., Tanyigna K. B. Urinary tract inferctions in a Nigerian Military Hospital. Niger. J. Microbiol 2001; 15 (1): 31-37.
[22]
Akinyemi K. O., Alabi S. A., Taiwo M. A., Omonigbehin E. A. Antimicrobial susceptibility pattern and plasmid profiles of pathogenic bacteria isolated from subjects with urinary tract infections in Lagos, Nigeria. Niger. Qtr. J. Hosp. Med 1997; 1: 7-11.
[23]
Okesola A. O., Oni A. A. Antimicrobial resistance among common bacterial pathogens in south western Nigeria. American-Eurasian J. Agric. Environ. Sci 2009; 5 (3): 327-330.
[24]
Mbata T. I. Prevalence and antibiogram of UTIs among prison immates in Nigeria. Int. J. Microbiol 2007; 3 (2): 6-12.
[25]
Kolawale A. S., Kolawole O. M., Kandaki-Olukemi Y. T., Babatunde S. K., Durowade K. A., Kolawole C. F. Prevalence of urinary tract infections (UTI) among patients attending DalhatuAraf Specialist Hospital, Lafia, Nasarawa State, Nigeria. Int J Med Sci2009; 1: 163-167.
[26]
El-Mahmood A. M., Atimi A. T., Tirmidhi B., Mohammed A. Antimicrobial susceptibility of some quinolone antibiotics against some urinary tract pathogens in a tertiary hospital, Yola, Adamawa State, Nigeria. J Clin Med Res 2009; 1: 26-34.
[27]
Snydman D. R. Clinical implications of multi-drug resistance in the intensive care unit. Scan J. Infect. Dis. 1991; 78: 54-63.
[28]
Savas L., Guvel S., OnlenY., Savas N., Duran N. Nosocomial urinary tract infections: microorganisms, antibiotic sensitivities and risk factors. West Indian Med. J. 2006; 55 (3): 1-9.
[29]
Otajevwo F. D. Urinary Tract Infection among Symptomatic Outpatients Visiting a Tertiary Hospital Based in Midwestern Nigeria. Global Journal of Health Science 2013; Vol. 5, No. 2; 187-199.
[30]
Inabo H. I., Obanibi H. B. T. Antimicrobial susceptibility of some urinary tract clinical isolates tocommonly used antibiotics. Afri. J. Biotech 2006; 5 (5), 487-489.
[31]
Mohammad E., Dariush G., Reza M., Vahhab P. Incidence and Antibiotic Susceptibility Pattern of Staphylococcus spp. in Urinary Tract Infections (UTI), IRAN, 2013-2014. Current Research in Bacteriology 2015; 8: 41-47.
[32]
Farajnia S., Alikhani M. Y., Ghotaslou C., Naghili B., Nakhlband A. Causative agents and antimicrobial susceptibilities of urinary tract infections in the Northwest of Iran. Int. J. Infect. Dis. 2009; 13: 140-144.
